OBR – News, Perspective, Catalyst

Today's Oncology News

Opt In Search Archives

FDA Approves First Immunotherapy for Initial Treatment ...

(FDA.gov) Apr 16, 2021 - Today, the U.S. Food and Drug Administration approved Opdivo (nivolumab), in combination with certain types of chemot...

Vaccines Won’t Protect Millions of Patients With ...

(New York Times) Apr 15, 2021 - Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing o...

Studies Suggest People with Blood Cancers May Not Be Op...

(ASH) Apr 16, 2021 - Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with c...

Featured Content

Leading Thoughts: Lung Cancer - Episode 1

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Toni Choueiri, MD, Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, discuss clinical progress in renal cell carcinoma (RCC)

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Neeraj Agarwal, MD, Professor of Medicine, Huntsman Cancer Institute, Presidential Endowed Chair of Cancer Research , Co-Leader, HCI Experimental Therapeutics Program, Director, Center of Investigational Therapeutics, Director, Genitourinary Oncology...

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Arjun Balar, MD, Director, Genitourinary Medical Oncology Program, NYU Langone’s Perlmutter Cancer Center, discuss clinical progress in bladder cancer

The pandemic has exacerbated health disparities that already existed for certain individuals with cancer. At a recent AACR virtual meeting on COVID-19 and cancer, presenters focused on some of the inequities impacting cancer patients and survivors across racial, ethnic, age, and gender lines, resulting in financial hardship, mental health symptoms, and ec...

At AMCCBS's March virtual meeting, COVID-19 was called a "disruptive innovator" for the challenges it's presented to oncology providers, including staffing shortages, evolving health regulations, and providing quality care to patients during a pandemic. Oncologists discussed the health crisis' long-term effects on cancer care and what positive lessons the...

Telehealth was quickly embraced by most oncology practices during the public health crisis after limited use. AMCCBS participants discussed telehealth's positives and negatives and debated how much "virtual care" should be utilized post-COVID for making informed, long-term decisions about patient treatment. OBR also reports on how electronic patient repor...

Podcasts

Bladder Cancer – Robert Figlin, MD, and Arjun Balar, MD, discuss clinical progress in bladder cancer

00:00

Listen on
Apple Podcasts

Listen on
Google Play

Listen on
Spotify

Title

Released

Prostate Cancer - Robert Figlin, MD, and Neeraj Agarwal, MD, discuss clinical progress in prostate cancer

02/22/21

Renal Cell Carcinoma (RCC) - Robert Figlin, MD and Toni Choueiri, MD, discuss clinical progress in renal cell carcino...

02/22/21

Breast Cancer – Robert Figlin, MD, and Adam Brufsky, MD, PhD, discuss clinical highlights from SABCS 2020

01/12/21

Chronic Lymphocytic Leukemia (CLL) – Robert Figlin, MD, and Mazyar Shadman, MD, MPH, discuss clinical highlight...

01/11/21

Expert Video Insights

Search by

William K. Oh, MD, summarizes outcomes from the ACIS study as presented at ASCO GU 2021

Tanya Dorff, MD, explains the design and outcomes of the ACIS clinical trial

OBR Green

View Archives

March 2021 Edition

At AMCCBS's March virtual meeting, COVID-19 was called a "disruptive innovator" for the challenges it's presented to oncology providers, including staffing shortages, evolving health regu...

March 2021 Edition

Telehealth was quickly embraced by most oncology practices during the public health crisis after limited use. AMCCBS participants discussed telehealth's positives and negatives and debate...

March 2021 Edition

The pandemic has exacerbated health disparities that already existed for certain individuals with cancer. At a recent AACR virtual meeting on COVID-19 and cancer, presenters focused on so...

Blog

New Treatment Directions Unveiled at WCLC 2020

Feb 01, 2021

By Ted Bosworth In early stage non-small cell lung cancer (NSCLC), one source of good news at the 2020 World Conference on Lung Cancer (WCLC 2020) was the effi...

ASH 2020 Advances Immunotherapies, Puts Spotlight on He...

Dec 14, 2020

By Mary Ellen Schneider This year’s annual meeting of the American Society of Hematology (ASH) featured new research on chimeric antigen receptor (CAR) T-cel...

DAY 4: Circulating Tumor Cells, HDAC Inhibition, and Ne...

Dec 11, 2020

by Chase Doyle Day 4 of the 2020 San Antonio Breast Cancer Symposium (SABCS) virtual meeting featured advances in early treatment monitoring, a surprising setb...

OBR Tools

Stemming from the user preference that you set, stay informed and increase your productivity via 27/7 web based access to Ontelligence^TM and a customized email alert system summarizing the most recent oncology-specific information available.

Learn More

The Oncology Business Dynamics Learning Platform addresses the need to have a high level of understanding of the non-clinical issues that are influencing the decision making process for hem/oncs today.

Learn More